48 articles
Rick Baehner, MD, Chief Medical Officer of Precision Oncology at Exact Sciences discusses a new study in "Urologic Oncology: Seminars and Original Inves...
Scarlett Gomez, Professor, Department of Epidemiology and Biostatistics, UCSF; Co-Leader, Cancer Control Program, UCSF Helen Diller Family Comprehensive...
Earle Burgess an oncologist from Charlotte, NC discusses prostate cancer, the second most common form of cancer in American men today.
37-year old Mical Roy discusses his stage II prostate cancer diagnosis in 2018 and his participation in the "Your Cancer Story" program which aims to he...
Neal Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center discusses the importance of patient-centric treatment decision-making a...
Wolff Distinguished Professor of Urology at Washington University School of Medicine, Siteman Cancer Center, and Barnes-Jewish Hospital discusses import...
Matthew Smith, MD, Professor of Medicine at Harvard Medical School and Director of the Genitourinary Malignancies Program at Massachusetts General Hospi...
Steve Shak, Chief Medical Officer at Exact Sciences discusses the publication of new analyses of two clinical studies that demonstrate for the first tim...
Andrew Krivoshik, SVP, and Oncology Therapeutic Area Head at Astellas Pharma US discusses the overall survival findings from the Phase 3 PROSPER trial i...
Aaron Katz, MD, Chairman of Urology at NYU Winthrop Hospital and Professor of Urology NYU School of Medicine, discusses the Oncotype DX Genomic Prostate...